Huakang Biomedical Holdings Company Limited 8622.HK Stock
Huakang Biomedical Holdings Company Limited Price Chart
Huakang Biomedical Holdings Company Limited 8622.HK Financial and Trading Overview
Contents
- Huakang Biomedical Holdings Company Limited Price Chart
- Huakang Biomedical Holdings Company Limited 8622.HK Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Huakang Biomedical Holdings Company Limited
- Q&A For Huakang Biomedical Holdings Company Limited Stock
| Huakang Biomedical Holdings Company Limited stock price | 0.13 HKD |
| Previous Close | 0.19 HKD |
| Open | 0.19 HKD |
| Bid | 0.18 HKD x 0 |
| Ask | 0.19 HKD x 0 |
| Day's Range | 0.19 - 0.2 HKD |
| 52 Week Range | 0.15 - 0.26 HKD |
| Volume | 520K HKD |
| Avg. Volume | 317.77K HKD |
| Market Cap | 76.68M HKD |
| Beta (5Y Monthly) | -0.201457 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8622.HK Valuation Measures
| Enterprise Value | 45.25M HKD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.0438378 |
| Price/Book (mrq) | 1.3602941 |
| Enterprise Value/Revenue | 1.796 |
| Enterprise Value/EBITDA | -17.283 |
Trading Information
Huakang Biomedical Holdings Company Limited Stock Price History
| Beta (5Y Monthly) | -0.201457 |
| 52-Week Change | -6.00000019% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.26 HKD |
| 52 Week Low | 0.15 HKD |
| 50-Day Moving Average | 0.18 HKD |
| 200-Day Moving Average | 0.19 HKD |
8622.HK Share Statistics
| Avg. Volume (3 month) | 317.77K HKD |
| Avg. Daily Volume (10-Days) | 312.8K HKD |
| Shares Outstanding | 414.47M |
| Float | 176.42M |
| Short Ratio | N/A |
| % Held by Insiders | 57.43% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -11.54% |
| Operating Margin (ttm) | -17.73% |
| Gross Margin | 67.28% |
| EBITDA Margin | -10.39% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | -5.090% |
Income Statement
| Revenue (ttm) | 25.19M HKD |
| Revenue Per Share (ttm) | 0.06 HKD |
| Quarterly Revenue Growth (yoy) | -2.39% |
| Gross Profit (ttm) | N/A |
| EBITDA | -2618250 HKD |
| Net Income Avi to Common (ttm) | -2908000 HKD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 33.3M HKD |
| Total Cash Per Share (mrq) | 0.08 HKD |
| Total Debt (mrq) | 1.88M HKD |
| Total Debt/Equity (mrq) | 3.32 HKD |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 0.136 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Huakang Biomedical Holdings Company Limited
| Country | Hong Kong |
| State | N/A |
| City | Wan Chai |
| Address | Effectual Building |
| ZIP | N/A |
| Phone | 852 2202 8988 |
| Website | https://www.huakangbiomedical.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 82 |
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China, Hong Kong, and Canada. The company provides male fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; and auxiliary reproductive supplies and equipment. It also offers healthcare products and supplements under the Nutronic brand through its websites, including nutronic.ca and nutronic.hk; offline channels, such as Eugenebaby and green price shops; and e-commerce platforms comprising Tmall, JD.com, Amazon, HKTVmall, Eugenebaby, etc. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is based in Wan Chai, Hong Kong.
Q&A For Huakang Biomedical Holdings Company Limited Stock
What is a current 8622.HK stock price?
Huakang Biomedical Holdings Company Limited 8622.HK stock price today per share is 0.13 HKD.
How to purchase Huakang Biomedical Holdings Company Limited stock?
You can buy 8622.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Huakang Biomedical Holdings Company Limited?
The stock symbol or ticker of Huakang Biomedical Holdings Company Limited is 8622.HK.
Which industry does the Huakang Biomedical Holdings Company Limited company belong to?
The Huakang Biomedical Holdings Company Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Huakang Biomedical Holdings Company Limited have in circulation?
The max supply of Huakang Biomedical Holdings Company Limited shares is 469.47M.
What is Huakang Biomedical Holdings Company Limited Price to Earnings Ratio (PE Ratio)?
Huakang Biomedical Holdings Company Limited PE Ratio is now.
What was Huakang Biomedical Holdings Company Limited earnings per share over the trailing 12 months (TTM)?
Huakang Biomedical Holdings Company Limited EPS is -0.02 HKD over the trailing 12 months.
Which sector does the Huakang Biomedical Holdings Company Limited company belong to?
The Huakang Biomedical Holdings Company Limited sector is Healthcare.